AAM
AMED
Alpine Associates Management’s Amedisys AMED Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $108M | Buy |
1,096,920
+104,800
| +11% | +$10.3M | 5.76% | 6 |
|
2025
Q1 | $91.9M | Buy |
992,120
+104,000
| +12% | +$9.63M | 4.81% | 7 |
|
2024
Q4 | $80.6M | Buy |
888,120
+27,403
| +3% | +$2.49M | 4.89% | 7 |
|
2024
Q3 | $83.1M | Sell |
860,717
-420,180
| -33% | -$40.6M | 3.81% | 10 |
|
2024
Q2 | $118M | Buy |
1,280,897
+11,000
| +0.9% | +$1.01M | 5.63% | 4 |
|
2024
Q1 | $117M | Sell |
1,269,897
-1,200
| -0.1% | -$111K | 4.56% | 7 |
|
2023
Q4 | $121M | Buy |
1,271,097
+237,600
| +23% | +$22.6M | 6.2% | 4 |
|
2023
Q3 | $96.5M | Buy |
1,033,497
+328,300
| +47% | +$30.7M | 5.06% | 9 |
|
2023
Q2 | $64.5M | Buy |
+705,197
| New | +$64.5M | 2.9% | 16 |
|